115 related articles for article (PubMed ID: 20001925)
1. Proteomic analysis of mitochondria in Raji cells following exposure to radiation: implications for radiotherapy response.
Jiang Y; Liu X; Fang X; Wang X
Protein Pept Lett; 2009; 16(11):1350-9. PubMed ID: 20001925
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment with rituximab enhances radiosensitivity of non-Hodgkin's lymphoma cells.
Skvortsova I; Popper BA; Skvortsov S; Saurer M; Auer T; Moser R; Kamleitner H; Zwierzina H; Lukas P
J Radiat Res; 2005 Jun; 46(2):241-8. PubMed ID: 15988143
[TBL] [Abstract][Full Text] [Related]
3. Comparative mitochondrial proteomic analysis of Rji cells exposed to adriamycin.
Jiang YJ; Sun Q; Fang XS; Wang X
Mol Med; 2009; 15(5-6):173-82. PubMed ID: 19209238
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-148b enhances the radiosensitivity of non-Hodgkin's Lymphoma cells by promoting radiation-induced apoptosis.
Wu Y; Liu GL; Liu SH; Wang CX; Xu YL; Ying Y; Mao P
J Radiat Res; 2012 Jul; 53(4):516-25. PubMed ID: 22843616
[TBL] [Abstract][Full Text] [Related]
5. Rituximab enhances radiation-triggered apoptosis in non-Hodgkin's lymphoma cells via caspase-dependent and - independent mechanisms.
Skvortsova I; Skvortsov S; Popper BA; Haidenberger A; Saurer M; Gunkel AR; Zwierzina H; Lukas P
J Radiat Res; 2006 Jun; 47(2):183-96. PubMed ID: 16819145
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells are significantly reduced in non-Hodgkin's lymphoma and express less CCR7 and CD62L.
Fiore F; Von Bergwelt-Baildon MS; Drebber U; Beyer M; Popov A; Manzke O; Wickenhauser C; Baldus SE; Schultze JL
Leuk Lymphoma; 2006 Apr; 47(4):613-22. PubMed ID: 16690519
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of ADAM12 contributes to accelerated cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphoma.
Yin H; Zhong F; Ouyang Y; Wang Q; Ding L; He S
Hematology; 2017 Oct; 22(9):527-535. PubMed ID: 28395594
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro.
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Acta Pharmacol Sin; 2006 Nov; 27(11):1438-46. PubMed ID: 17049119
[TBL] [Abstract][Full Text] [Related]
9. Curcumin enhances the response of non-Hodgkin's lymphoma cells to ionizing radiation through further induction of cell cycle arrest at the G2/M phase and inhibition of mTOR phosphorylation.
Qiao Q; Jiang Y; Li G
Oncol Rep; 2013 Jan; 29(1):380-6. PubMed ID: 23117293
[TBL] [Abstract][Full Text] [Related]
10. Proteomics Based Identification of Proteins with Deregulated Expression in B Cell Lymphomas.
Wu R; Nijland M; Rutgers B; Veenstra R; Langendonk M; van der Meeren LE; Kluin PM; Li G; Diepstra A; Chiu JF; van den Berg A; Visser L
PLoS One; 2016; 11(1):e0146624. PubMed ID: 26752561
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of TRIP6 promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR) via regulating nuclear p27(Kip1) expression in non-Hodgkin's lymphoma.
Miao X; Xu X; Wu Y; Zhu X; Chen X; Li C; Lu X; Chen Y; Liu Y; Huang J; Wang Y; He S
Tumour Biol; 2016 Jan; 37(1):1369-78. PubMed ID: 26298725
[TBL] [Abstract][Full Text] [Related]
13. Analysis of serum proteome profiles of non-Hodgkin lymphoma for biomarker identification.
Zhang MZ; Sun ZC; Fu XR; Nan FF; Fan QX; Wu XA; Geng L; Ma W; Wang RL
J Proteomics; 2009 Aug; 72(6):952-9. PubMed ID: 19361584
[TBL] [Abstract][Full Text] [Related]
14. [Expression, localization and interrelationship of P27kip1 and cyclin D3 in non-Hodgkin's lymphoma].
Zhang DM; Lu JX; Shen AG; Chen L; He S; Shao XY; Liu HO; Cheng C
Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):723-7. PubMed ID: 16620575
[TBL] [Abstract][Full Text] [Related]
15. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
Møller MB; Nielsen O; Pedersen NT
Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
[TBL] [Abstract][Full Text] [Related]
16. miRNA and Proteomic Dysregulation in Non-Small Cell Lung Cancer in Response to Cigarette Smoke.
Babu N; Advani J; Solanki HS; Patel K; Jain A; Khan AA; Radhakrishnan A; Sahasrabuddhe NA; Mathur PP; Nair B; Keshava Prasad TS; Chang X; Sidransky D; Gowda H; Chatterjee A
Microrna; 2018; 7(1):38-53. PubMed ID: 29299995
[TBL] [Abstract][Full Text] [Related]
17. The feedback loop of LITAF and BCL6 is involved in regulating apoptosis in B cell non-Hodgkin's-lymphoma.
Shi Y; Kuai Y; Lei L; Weng Y; Berberich-Siebelt F; Zhang X; Wang J; Zhou Y; Jiang X; Ren G; Pan H; Mao Z; Zhou R
Oncotarget; 2016 Nov; 7(47):77444-77456. PubMed ID: 27764808
[TBL] [Abstract][Full Text] [Related]
18. A systematic overview of radiation therapy effects in non-Hodgkin's lymphoma.
Gustavsson A; Osterman B; Cavallin-Ståhl E
Acta Oncol; 2003; 42(5-6):605-19. PubMed ID: 14596518
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic and proteomic approaches reveal biological basis of intraoperative radiotherapy-treated tumor bed modification in breast cancer patients: A pilot study.
Shahani M; Shakeri J; Akbari ME; Arefnezhad B; Tafti A; Zali H; Nafisi N; Hashemi M; Rezaei-Tavirani M; Mohammadpour S; Salami SAR; Mirzai HR; Samsami M; Ezabady SHJ; Akbari A
J Proteomics; 2020 Feb; 212():103596. PubMed ID: 31759177
[TBL] [Abstract][Full Text] [Related]
20. Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma.
Wang Y; Wu Y; Miao X; Zhu X; Miao X; He Y; Zhong F; Ding L; Liu J; Tang J; Huang Y; Xu X; He S
Int J Biol Macromol; 2015 Nov; 81():809-17. PubMed ID: 26341817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
